Retraction notice to “Bone Marrow Ablation Demonstrates That Excess Endogenous Parathyroid Hormone Plays Distinct Roles in Trabecular and Cortical Bone” [Am J Pathol 181 (2012) 234–244, (S0002944012003276), (10.1016/j.ajpath.2012.03.038)];Bone marrow ablation demonstrates that excess endogenous parathyroid hormone plays distinct roles in trabecular and cortical bone

American Journal of Pathology

Volumn 181, Issue 1, 2012, Pages 234-244

  Yan, Jun ^a   Sun, Weiwei ^b   Zhang, Jing ^b   Goltzman, David ^c   Miao, Dengshun ^b  

^a SOOCHOW UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; COLLAGEN TYPE 1; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; PHOSPHORUS;

ABLATION THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MARROW ABLATION; BONE TISSUE; BONE TURNOVER; CALCIUM BLOOD LEVEL; CATABOLISM; CELL STIMULATION; CONTROLLED STUDY; CORTICAL BONE; FEMUR; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIBIA; TRABECULAR BONE; WILD TYPE;

EID: 84862701293     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2024.08.004     Document Type: Erratum

References (49)

1. Miao D, He B, Karaplis AC, Goltzman D: Parathyroid hormone is essential for normal fetal bone formation. J Clin Invest 2002, 109:1173-1182
2. Xue Y, Karaplis AC, Hendy GN, Goltzman D, Miao D: Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development. Hum Mol Genet 2005, 14:1515-1528
3. Cao G, Gu Z, Ren Y, Shu L, Tao C, Karaplis A, Goltzman D, Miao D: Parathyroid hormone contributes to regulating milk calcium content and modulates neonatal bone formation cooperatively with calcium. Endocrinology 2009, 150:561-569
4. Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, Hendy GN, Goltzman D: Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci USA 2001, 98:7498-7503
5. Carlson J, Zhang Q, Bennett A, Vignery A: Deletion of mitogen-activated protein kinase phosphatase 1 modifies the response to mechanical bone marrow ablation in a mouse model. Comp Med 2009, 59:221-226
6. Chen XD, Allen MR, Bloomfield S, Xu T, Young M: Biglycan-deficient mice have delayed osteogenesis after marrow ablation. Calcif Tissue Int 2003, 72:577-582
7. Gerstenfeld LC, Cho TJ, Kon T, Aizawa T, Cruceta J, Graves BD, Einhorn TA: Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs 2001, 169:285-294
8. Kuroda S, Virdi AS, Dai Y, Shott S, Sumner DR: Patterns and localization of gene expression during intramembranous bone regeneration in the rat femoral marrow ablation model. Calcif Tissue Int 2005, 77:212-225
9. Morinobu M, Nakamoto T, Hino K, Tsuji K, Shen ZJ, Nakashima K, Nifuji A, Yamamoto H, Hirai H, Noda M: The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation. J Exp Med 2005, 201:961-970
10. Tanaka H, Wakisaka A, Ogasa H, Kawai S, Liang CT: Local and systemic expression of insulin-like growth factor-I (IGF-I) mRNAs in rat after bone marrow ablation. Biochem Biophys Res Commun 2001, 287:1157-1162
11. Tsuji K, Komori T, Noda M: Aged mice require full transcription factor, Runx2/Cbfa1, gene dosage for cancellous bone regeneration after bone marrow ablation. J Bone Miner Res 2004, 19:1481-1489
12. Yamashita T, Yoshitake H, Tsuji K, Kawaguchi N, Nabeshima Y, Noda M: Retardation in bone resorption after bone marrow ablation in klotho mutant mice. Endocrinology 2000, 141:438-445
13. Amsel S, Maniatis A, Tavassoli M, Crosby WH: The significance of intramedullary cancellous bone formation in the repair of bone marrow tissue. Anat Rec 1969, 164:101-111
14. Bab IA: Postablation bone marrow regeneration: an in vivo model to study differential regulation of bone formation and resorption. Bone 1995, 17(4 Suppl):437S-441S
15. Patt HM, Maloney MA: Bone marrow regeneration after local injury: a review. Exp Hematol 1975, 3:135-148
16. Suva LJ, Seedor JG, Endo N, Quartuccio HA, Thompson DD, Bab I, Rodan GA: Pattern of gene expression following rat tibial marrow ablation. J Bone Miner Res 1993, 8:379-388
17. Zhang Q, Carlson J, Ke HZ, Li J, Kim M, Murphy K, Mehta N, Gilligan J, Vignery A: Dramatic increase in cortical thickness induced by femoral marrow ablation followed by a 3-month treatment with PTH in rats [Erratum appeared in J Bone Miner Res 2010, 25:2089-2090]. J Bone Miner Res 2010, 25:1350-1359
18. Zhang Q, Cuartas E, Mehta N, Gilligan J, Ke HZ, Saltzman WM, Kotas M, Ma M, Rajan S, Chalouni C, Carlson J, Vignery A: Replacement of bone marrow by bone in rat femurs: the bone bioreactor. Tissue Eng Part A 2008, 14:237-246
19. Liu H, Guo J, Wang L, Chen N, Karaplis A, Goltzman D, Miao D: Distinctive anabolic roles of 1,25-dihydroxyvitamin D(3) and parathyroid hormone in teeth and mandible versus long bones. J Endocrinol 2009, 203:203-213
20. Sun W, Liu J, Zhou X, Xiao Y, Karaplis A, Pollak MR, Brown E, Goltzman D, Miao D: Alterations in phosphorus, calcium and PTHrP contribute to defects in dental and dental alveolar bone formation in calcium-sensing receptor-deficient mice. Development 2010, 137:985-992
21. Miao D, Bai X, Panda D, McKee M, Karaplis A, Goltzman D: Osteomalacia in hyp mice is associated with abnormal Phex expression and with altered bone matrix protein expression and deposition. Endocrinology 2001, 142:926-939
22. Panda DK, Miao D, Bolivar I, Li J, Huo R, Hendy GN, Goltzman D: Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 2004, 279:16754-16766
23. Miao D, Scutt A: Recruitment, augmentation and apoptosis of rat osteoclasts in 1,25-(OH)2D3 response to short-term treatment with 1,25-dihydroxyvitamin D3 in vivo. BMC Musculoskelet Disord 2002, 3:16
24. Miao D, Scutt A: Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage. J Histochem Cytochem 2002, 50:333-340
25. Zhang R, Lu Y, Ye L, Yuan B, Yu S, Qin C, Xie Y, Gao T, Drezner MK, Bonewald LF, Feng JQ: Unique roles of phosphorus in endochondral bone formation and osteocyte maturation. J Bone Miner Res 2011, 26:1047-1056
26. Miao D, He B, Lanske B, Bai XY, Tong XK, Hendy GN, Goltzman D, Karaplis AC: Skeletal abnormalities in Pth-null mice are influenced by dietary calcium. Endocrinology 2004, 145:2046-2053
27. Wigner NA, Luderer HF, Cox MK, Sooy K, Gerstenfeld LC, Demay MB: Acute phosphate restriction leads to impaired fracture healing and resistance to BMP-2. J Bone Miner Res 2010, 25:724-733
28. Stein EM, Dempster DW, Udesky J, Zhou H, Bilezikian JP, Shane E, Silverberg SJ: Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism. Bone 2011, 48:557-561
29. Richard C, Huo R, Samadfam R, Bolivar I, Miao D, Brown EM, Hendy GN, Goltzman D: The calcium-sensing receptor and 25-hydroxyvitamin D-1alpha-hydroxylase interact to modulate skeletal growth and bone turnover. J Bone Miner Res 2010, 25:1627-1636
30. Datta HK, MacIntyre I, Zaidi M: The effect of extracellular calcium elevation on morphology and function of isolated rat osteoclasts. Biosci Rep 1989, 9:747-751
31. O'Brien CA, Plotkin LI, Galli C, Goellner JJ, Gortazar AR, Allen MR, Robling AG, Bouxsein M, Schipani E, Turner CH, Jilka RL, Weinstein RS, Manolagas SC, Bellido T: Control of bone mass and remodeling by PTH receptor signaling in osteocytes. PLoS One 2008, 3:e2942
32. Swarthout JT, D'Alonzo RC, Selvamurugan N, Partridge NC: Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Gene 2002, 282:1-17
33. Miao D, He B, Jiang Y, Kobayashi T, Soroceanu MA, Zhao J, Su H, Tong X, Amizuka N, Gupta A, Genant HK, Kronenberg HM, Goltzman D, Karaplis AC: Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest 2005, 115:2402-2411
34. Goltzman D: Discoveries, drugs and skeletal disorders. Nat Rev Drug Discov 2002, 1:784-796
35. Bellido T, Ali AA, Plotkin LI, Fu Q, Gubrij I, Roberson PK, Weinstein RS, O'Brien CA, Manolagas SC, Jilka RL: Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem 2003, 278:50259-50272
36. Bikle DD, Sakata T, Leary C, Elalieh H, Ginzinger D, Rosen CJ, Beamer W, Majumdar S, Halloran BP: Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. J Bone Miner Res 2002, 17:1570-1578
37. Wang Y, Nishida S, Boudignon BM, Burghardt A, Elalieh HZ, Hamilton MM, Majumdar S, Halloran BP, Clemens TL, Bikle DD: IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone. J Bone Miner Res 2007, 22:1329-1337
38. Yamaguchi M, Ogata N, Shinoda Y, Akune T, Kamekura S, Terauchi Y, Kadowaki T, Hoshi K, Chung UI, Nakamura K, Kawaguchi H: Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice. Endocrinology 2005, 146:2620-2628
39. Burr DB, Hirano T, Turner CH, Hotchkiss C, Brommage R, Hock JM: Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys. J Bone Miner Res 2001, 16:157-165
40. Parisien M, Silverberg SJ, Shane E, de la Cruz L, Lindsay R, Bilezikian JP, Dempster DW: The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab 1990, 70:930-938
41. Silverberg SJ, Shane E, de la Cruz L, Dempster DW, Feldman F, Seldin D, Jacobs TP, Siris ES, Cafferty M, Parisien MV, Lindsay R, Clemens TL, Bilezikian JP: Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 1989, 4:283-291
42. Zhou H, Shen V, Dempster DW, Lindsay R: Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat. J Bone Miner Res 2001, 16:1300-1307
43. Rhee Y, Bivi N, Farrow E, Lezcano V, Plotkin LI, White KE, Bellido T: Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Bone 2011, 49:636-643
44. Christiansen P, Steiniche T, Brixen K, Hessov I, Melsen F, Charles P, Mosekilde L: Primary hyperparathyroidism: biochemical markers and bone mineral density at multiple skeletal sites in Danish patients. Bone 1997, 21:93-99
45. Christiansen P, Steiniche T, Vesterby A, Mosekilde L, Hessov I, Melsen F: Primary hyperparathyroidism: iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods. Bone 1992, 13:41-49
46. Dempster DW, Müller R, Zhou H, Kohler T, Shane E, Parisien M, Silverberg SJ, Bilezikian JP: Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism. Bone 2007, 41:19-24
47. Dempster DW, Parisien M, Silverberg SJ, Liang XG, Schnitzer M, Shen V, Shane E, Kimmel DB, Recker R, Lindsay R, Bilezikian JP: On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab 1999, 84:1562-1566
48. Parisien M, Cosman F, Mellish RW, Schnitzer M, Nieves J, Silverberg SJ, Shane E, Kimmel D, Recker RR, Bilezikian JP, Lindsay R, Dempster DW: Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women. J Bone Miner Res 1995, 10:1393-1399
49. Parisien M, Mellish RW, Silverberg SJ, Shane E, Lindsay R, Bilezikian JP, Dempster DW: Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis. J Bone Miner Res 1992, 7:913-919